Flavodoxin
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | {{STRUCTURE_2bmv| PDB=2bmv | SIZE=300| SCENE=Flavodoxin/Cv/1 |right|CAPTION=Apo-Flavodoxin from ''Helicobacter pylori'' complexed with benzamidine and chloride ion, [[2bmv]] }} | ||
- | [[Flavodoxin]] (FDX) is a bacterial protein which contains flavin mononucleotide (FMN) or flavin adenine dinucleotide (FAD). It participates in nitrogen metabolism and reduces N2 to NH3 while changing from its oxidized quinone state FDX-ox via semiquinone FDX-sq to its reduced hydroquinone state FDX-red. '''NrdI''' is a FDX which is involved in ribonucleotide reduction. '''WrbA (Tryptophan Repressor-Binding Protein)''' is also FDX. In ''E. coli'' there are 2 distinct FDX I and II. | + | <StructureSection load='2bmv' size='350' side='right' scene='' caption='Apo-Flavodoxin from ''Helicobacter pylori'' complexed with benzamidine and chloride ion (PDB code [[2bmv]]) '> |
+ | |||
+ | [[Flavodoxin]] (FDX) is a bacterial protein which contains flavin mononucleotide (FMN) or flavin adenine dinucleotide (FAD). It participates in nitrogen metabolism and reduces N2 to NH3 while changing from its oxidized quinone state FDX-ox via semiquinone FDX-sq to its reduced hydroquinone state FDX-red<ref>PMID:8747466</ref>. '''NrdI''' is a FDX which is involved in ribonucleotide reduction. '''WrbA (Tryptophan Repressor-Binding Protein)''' is also FDX. In ''E. coli'' there are 2 distinct flavodoxins: FDX I and II. | ||
+ | </StructureSection> | ||
== 3D Structures of Flavodoxin == | == 3D Structures of Flavodoxin == | ||
Line 67: | Line 69: | ||
**[[1j8q]] - DvFDX<br /> | **[[1j8q]] - DvFDX<br /> | ||
}} | }} | ||
+ | == References == | ||
+ | <references/> | ||
+ | |||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 17:46, 22 January 2016
|
3D Structures of Flavodoxin
Updated on 22-January-2016
References
- ↑ Athappilly FK, Hendrickson WA. Structure of the biotinyl domain of acetyl-coenzyme A carboxylase determined by MAD phasing. Structure. 1995 Dec 15;3(12):1407-19. PMID:8747466